To validate the function of Npm1 in leukemogenesis, we disrupted it in Myc-overexpressing HSPCs by CRISPR/Cas9 (S5A–S5C Fig) and found that Npm1 loss significantly extended the latency of Myc-driven AML in mice (Fig 4D). Here, MYC is linked to acute myeloid leukemia.